Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 1 395 IDR 2.57% Market Closed
Market Cap: 20.6T IDR
Have any thoughts about
Medikaloka Hermina Tbk PT?
Write Note

Medikaloka Hermina Tbk PT
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medikaloka Hermina Tbk PT
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medikaloka Hermina Tbk PT
IDX:HEAL
Cash & Cash Equivalents
Rp672B
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Siloam International Hospitals Tbk PT
IDX:SILO
Cash & Cash Equivalents
Rp961.7B
CAGR 3-Years
6%
CAGR 5-Years
46%
CAGR 10-Years
12%
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Cash & Cash Equivalents
Rp525.8B
CAGR 3-Years
0%
CAGR 5-Years
131%
CAGR 10-Years
N/A
S
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
Cash & Cash Equivalents
Rp134.1B
CAGR 3-Years
-20%
CAGR 5-Years
24%
CAGR 10-Years
-8%
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
Cash & Cash Equivalents
Rp1.5T
CAGR 3-Years
160%
CAGR 5-Years
86%
CAGR 10-Years
30%
F
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
Cash & Cash Equivalents
Rp1T
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medikaloka Hermina Tbk PT
Glance View

Market Cap
20.8T IDR
Industry
Health Care

PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).

HEAL Intrinsic Value
1 284.18 IDR
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Medikaloka Hermina Tbk PT's Cash & Cash Equivalents?
Cash & Cash Equivalents
672B IDR

Based on the financial report for Sep 30, 2024, Medikaloka Hermina Tbk PT's Cash & Cash Equivalents amounts to 672B IDR.

What is Medikaloka Hermina Tbk PT's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
9%

Over the last year, the Cash & Cash Equivalents growth was -27%. The average annual Cash & Cash Equivalents growth rates for Medikaloka Hermina Tbk PT have been 23% over the past three years , 9% over the past five years .

Back to Top